MetLife Financial Statements (MET)
|
|
|
|
Report date
|
|
|
19.02.2021 |
18.02.2022 |
31.12.2022 |
23.02.2023 |
16.02.2024 |
|
01.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
67 842 |
71 080 |
69 898 |
69 898 |
66 901 |
|
71 348 |
|
Operating Income, bln rub |
|
|
5 067 |
5 486 |
0.000 |
3 105 |
66 901 |
|
18 474 |
|
EBITDA, bln rub |
? |
|
8 459 |
10 132 |
3 778 |
7 975 |
3 925 |
|
830.0 |
|
Net profit, bln rub |
? |
|
5 407 |
6 855 |
2 539 |
2 354 |
1 578 |
|
3 762 |
|
|
OCF, bln rub |
? |
|
11 639 |
12 596 |
4 428 |
13 204 |
13 721 |
|
15 169 |
|
CAPEX, bln rub |
? |
|
4 269 |
4 360 |
0.000 |
0.000 |
1 170 |
|
383.0 |
|
FCF, bln rub |
? |
|
7 370 |
16 956 |
4 428 |
13 204 |
13 721 |
|
14 786 |
|
Dividend payout, bln rub
|
|
|
1 859 |
1 842 |
5 168 |
1 783 |
1 764 |
|
1 985 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
34.4% |
26.9% |
203.5% |
75.7% |
111.8% |
|
52.8% |
|
|
OPEX, bln rub |
|
|
62 775 |
65 594 |
0.000 |
67 039 |
66 407 |
|
27 102 |
|
Cost of production, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
494.0 |
|
0.000 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
913.0 |
920.0 |
938.0 |
938.0 |
1 045 |
|
1 047 |
|
|
Assets, bln rub |
|
|
795 146 |
759 708 |
666 611 |
666 611 |
687 584 |
|
704 976 |
|
Net Assets, bln rub |
? |
|
74 558 |
67 482 |
27 040 |
27 040 |
30 015 |
|
30 885 |
|
Debt, bln rub |
|
|
18 149 |
17 430 |
17 980 |
17 980 |
18 828 |
|
15 682 |
|
Cash, bln rub |
|
|
378 508 |
367 497 |
301 910 |
301 910 |
302 051 |
|
315 544 |
|
Net debt, bln rub |
|
|
-360 359 |
-350 067 |
-283 930 |
-283 930 |
-283 223 |
|
-299 862 |
|
|
Ordinary share price, rub |
|
|
47.0 |
62.5 |
72.4 |
72.4 |
66.1 |
|
60.0 |
|
Number of ordinary shares, mln |
|
|
907.8 |
862.7 |
779.1 |
803.2 |
762.4 |
|
699.3 |
|
|
Market cap, bln rub |
|
|
42 621 |
53 910 |
56 383 |
58 128 |
50 420 |
|
41 965 |
|
EV, bln rub |
? |
|
-317 738 |
-296 157 |
-227 547 |
-225 802 |
-232 803 |
|
-257 897 |
|
Book value, bln rub |
|
|
45 758 |
39 614 |
17 743 |
-7 716 |
20 779 |
|
21 730 |
|
|
EPS, rub |
? |
|
5.96 |
7.95 |
3.26 |
2.93 |
2.07 |
|
5.38 |
|
FCF/share, rub |
|
|
8.12 |
19.7 |
5.68 |
16.4 |
18.0 |
|
21.1 |
|
BV/share, rub |
|
|
50.4 |
45.9 |
22.8 |
-9.61 |
27.3 |
|
31.1 |
|
|
EBITDA margin, % |
? |
|
12.5% |
14.3% |
5.41% |
11.4% |
5.87% |
|
1.16% |
|
Net margin, % |
? |
|
7.97% |
9.64% |
3.63% |
3.37% |
2.36% |
|
5.27% |
|
FCF yield, % |
? |
|
17.3% |
31.5% |
7.85% |
22.7% |
27.2% |
|
35.2% |
|
ROE, % |
? |
|
7.25% |
10.2% |
9.39% |
8.71% |
5.26% |
|
12.2% |
|
ROA, % |
? |
|
0.68% |
0.90% |
0.38% |
0.35% |
0.23% |
|
0.53% |
|
|
P/E |
? |
|
7.88 |
7.86 |
22.2 |
24.7 |
32.0 |
|
11.2 |
|
P/FCF |
|
|
5.78 |
3.18 |
12.7 |
4.40 |
3.67 |
|
2.84 |
|
P/S |
? |
|
0.63 |
0.76 |
0.81 |
0.83 |
0.75 |
|
0.59 |
|
P/BV |
? |
|
0.93 |
1.36 |
3.18 |
-7.53 |
2.43 |
|
1.93 |
|
EV/EBITDA |
? |
|
-37.6 |
-29.2 |
-60.2 |
-28.3 |
-59.3 |
|
-310.7 |
|
Debt/EBITDA |
|
|
-42.6 |
-34.6 |
-75.2 |
-35.6 |
-72.2 |
|
-361.3 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
|
|
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
6.29% |
6.13% |
0.00% |
0.00% |
1.75% |
|
0.54% |
|
| MetLife shareholders |
